Acute Withdrawal From Smoked Cocaine - 9
NCT00000292 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to develop an experimental paradigm to examine acute withdrawal symptoms from cocaine.
Conditions
- Cocaine-Related Disorders
- Substance Withdrawal Syndrome
- Substance-Related Disorders
Interventions
- PROCEDURE
-
Cocaine
Sponsors & Collaborators
- collaborator OTHER
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Dorothy Hatsukami, Ph.D. · University of Minnesota
Study Design
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 21 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-04-30
- Completion
- 2001-12-31
Countries
- United States
Study Locations
More Related Trials
-
Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence
NCT00385268 ·Status: COMPLETED ·Phase: PHASE2
-
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
NCT02444208 ·Status: COMPLETED ·Phase: NA
-
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
NCT00000286 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315 ·Status: UNKNOWN ·Phase: PHASE1
-
Effects of Labetalol on Human Cocaine Use - 8
NCT00000291 ·Status: COMPLETED ·Phase: PHASE2
-
New Medication Treatment for Stimulant Dependence
NCT00689572 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Amphetamine Withdrawal in Humans
NCT01215929 ·Status: COMPLETED ·Phase: PHASE2
-
Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study
NCT00653263 ·Status: COMPLETED
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
The Therapeutic Workplace Initiation Study
NCT00249470 ·Status: COMPLETED ·Phase: NA
-
Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9
NCT00015275 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Intranasal Oxytocin During Detoxification of Crack Cocaine
NCT04306354 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6
NCT00000303 ·Status: COMPLETED ·Phase: PHASE2
-
Modafinil Treatment for Cocaine-Dependent Individuals
NCT00129285 ·Status: COMPLETED ·Phase: PHASE2
-
Naltrexone in Treatment of Cocaine Dependence - 5
NCT00015080 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Cocaine Use and Withdrawal on Sleep
NCT07119567 ·Status: RECRUITING
-
Effects of Carvedilol on Cocaine Use in Humans - 11
NCT00000294 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Effects in Humans: Physiology and Behavior - 1
NCT00000200 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel Anti-Obesity Drug Combination as a Pharmacotherapy for Cocaine Dependence
NCT01739192 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management
NCT00292110 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of N-acetylcysteine on the Craving Symptoms of Abstinent Hospitalized Patients With Cocaine Addiction
NCT03423667 ·Status: TERMINATED ·Phase: PHASE2
-
Dose Response Trial of Pergolide for Cocaine Dependence - 1
NCT00000248 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1
NCT00136825 ·Status: COMPLETED ·Phase: PHASE1
-
Carbamazepine Treatment for Cocaine Dependence - 5
NCT00000191 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Varenicline in Methadone-Stabilized Cocaine Users
NCT00567320 ·Status: COMPLETED ·Phase: NA